Intuitive Surgical (ISRG) 10-K Summary — Year Ended Dec 31, 2023
The company is a medical device manufacturer focused on robotic-assisted surgery. Revenue grew in the most recent fiscal year, and the company maintained strong operating cash flow.
Key takeaway
Year ended Dec 31, 2023 · FY2025 10-K
The company is a medical device manufacturer focused on robotic-assisted surgery. Revenue grew in the most recent fiscal year, and the company maintained strong operating cash flow.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$7.1B
Revenue reported for the fiscal year.
Operating income
$1.8B
Income from operations reported for the year.
Net income
$1.8B
Net income reported for the year.
Operating cash flow
$1.8B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $5.7B | n/a |
| Dec 31, 2022 | $6.2B | +9.0% |
| Dec 31, 2023 | $7.1B | +14.5% |
Business overview
Intuitive Surgical, Inc. develops and markets products for surgical procedures. The company devotes resources to expand the adoption and acceptance of its products.
Financial performance
Revenue increased compared to the prior year. Operating income, net income, and operating cash flow were all at substantial levels.
Material risks
The supplied filing context does not include specific risk factor descriptions. No material risks can be identified from the provided sections.
Liquidity and capital
The company's primary liquidity sources are operations and equity-related proceeds. Cash and investments grew, and the company plans to continue investing in product adoption expansion.
What to watch
Future filings should be monitored for updates on procedure adoption and product acceptance.